Hepion Pharmaceuticals, Inc.
HEPA
$0.3171
$0.01966.59%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -13.19M | -22.70M | -28.37M | -38.52M | -48.93M |
| Total Depreciation and Amortization | 30.80K | 43.10K | 61.60K | 79.90K | 67.10K |
| Total Amortization of Deferred Charges | 1.27M | 474.60K | -- | -- | -- |
| Total Other Non-Cash Items | -3.64M | 792.30K | 1.01M | 4.36M | 5.00M |
| Change in Net Operating Assets | -2.68M | -4.67M | -7.49M | -2.21M | 2.97M |
| Cash from Operations | -18.22M | -26.07M | -34.78M | -36.29M | -40.89M |
| Capital Expenditure | -- | -300.00 | 2.30K | -14.20K | -14.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -600.00K | -600.00K | -- | -- | -- |
| Cash from Investing | -600.00K | -600.30K | 2.30K | -14.20K | -14.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.35M | 8.84M | 6.34M | 6.34M | 4.50M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.35M | 8.84M | 6.34M | 6.34M | 4.50M |
| Foreign Exchange rate Adjustments | 87.10K | 33.90K | 29.90K | 73.00K | 5.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.38M | -17.79M | -28.41M | -29.89M | -36.40M |